Physician profile
Jennifer K Hepp
NPI 1316072101
$17,041.58
in general payments reported to CMS, 2019-2025
77 companies · $2,040 in 2025
The $2,040 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,008 · 2020: $2,540 · 2021: $3,208 · 2022: $2,705 · 2023: $2,593 · 2024: $1,948 · 2025: $2,040.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,487 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,486.64 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,778.15 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,528.00 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,237.83 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $1,234.80 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $989.01 | 2019-2025 | |
| Allergan, INC. | $779.71 | 2019-2020 | |
| Amgen INC. | $480.67 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $418.65 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Eisai INC. | $378.18 | 2020-2022 | |
| Astellas Pharma US INC | $364.83 | 2019-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $345.53 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $293.18 | 2019-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $291.33 | 2019-2025 | Spravato, Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.55 | 2019-2023 | Glyxambi, Synjardy, Tradjenta |
| Amneal Pharmaceuticals LLC | $264.45 | 2019-2022 |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $257.65 | 2019-2023 | Airduo Digihaler |
| Exact Sciences Corporation | $256.11 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $238.98 | 2024-2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $238.12 | 2022 | |
| Merck Sharp & Dohme LLC | $236.09 | 2019-2023 | Dificid, Gardasil 9, M-M-R II |
| Biogen, INC. | $233.85 | 2020-2022 | |
| Qol Medical, LLC | $221.35 | 2019-2021 | |
| Ibsa Pharma INC. | $211.36 | 2019-2023 | Tirosint, Licart |
| Optinose US, INC. | $205.05 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $204.12 | 2021 | |
| Vanda Pharmaceuticals INC. | $180.22 | 2020-2021 | |
| Esperion Therapeutics, INC. | $179.28 | 2020-2025 | Nexletol |
| Bausch Health US, LLC | $151.72 | 2020-2025 | Aplenzin |
| Avanir Pharmaceuticals, INC. | $138.20 | 2019-2022 | |
| Exeltis, USA INC. | $128.98 | 2020-2025 | Slynd |
| Antares Pharma, INC. | $116.69 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $116.06 | 2024-2025 | Gemtesa |
| Abbott Laboratories | $106.98 | 2023-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $103.26 | 2019-2022 | |
| Axsome Therapeutics, INC. | $98.61 | 2023-2025 | Symbravo, Auvelity, Sunosi |
| Therapeuticsmd, INC. | $95.22 | 2019-2022 | |
| Inspire Medical Systems, INC. | $87.43 | 2023-2024 | Inspire |
| Daiichi Sankyo INC. | $86.71 | 2020-2021 | |
| Shire North American Group INC | $83.89 | 2019 | |
| Boston Scientific Corporation | $72.25 | 2021-2023 | |
| Currax Pharmaceuticals LLC | $70.65 | 2022-2024 | Contrave, Nexlizet, Nexletol |
| Kowa Pharmaceuticals America, INC. | $69.91 | 2019-2022 | |
| Corium, LLC | $69.79 | 2022-2023 | Azstarys |
| Idorsia Pharmaceuticals US INC | $64.09 | 2022-2024 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $62.16 | 2019-2023 | Eliquis |
| Organon LLC | $61.69 | 2023 | Nexplanon |
| Insightec,INC | $55.31 | 2023 | Exablate |
| Acella Pharmaceuticals, LLC | $52.81 | 2024-2025 | NP Thyroid 60 |
| Amarin Pharma, INC. | $48.05 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $45.54 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.80 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $39.65 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $39.61 | 2023 | Nuedexta |
| Jazz Pharmaceuticals INC. | $36.89 | 2021 | |
| Alkermes, INC. | $36.76 | 2021 | |
| Collegium Pharmaceutical, INC. | $35.28 | 2022 | |
| Medtronic, INC. | $34.88 | 2023 | Intellis Adaptivestim |
| Aimmune Therapeutics, INC. | $34.45 | 2025 | Zenpep |
| Lucid Diagnostics INC. | $30.66 | 2022-2024 | |
| Ironwood Pharmaceuticals, INC | $29.99 | 2019-2020 | |
| Heartflow, INC. | $29.48 | 2025 | |
| Horizon Therapeutics Plc | $29.16 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $28.59 | 2019 | |
| Brainsway USA INC | $26.95 | 2022 | |
| Romark Laboratories, Lc | $26.47 | 2020 | |
| Hologic Sales and Service, LLC | $25.23 | 2024 | Thinprep 2000 Processor, Aptima |
| Ferring Pharmaceuticals INC. | $24.73 | 2021 | |
| Aytu Biopharma, INC. | $24.60 | 2019 | |
| Cleerly, INC. | $22.02 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Alfasigma USA, INC. | $21.66 | 2022 | |
| Hikma Pharmaceuticals USA | $19.90 | 2019 | |
| Clarus Therapeutics INC. | $19.48 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $18.27 | 2019 | |
| Millicent US INC | $17.91 | 2024 | Femring, Intrarosa |
| Regeneron Healthcare Solutions, INC. | $16.11 | 2023 | Evkeeza |
| Inogen, INC. | $15.19 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Cequr Corporation | $11.81 | 2024 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hepp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.